Yuto Hibino

Yokohama City University Medical Center — Japan

Medicine · Health Sciences

2h-index10citations13works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(6), CNS Lymphoma Diagnosis and Treatment(5), Chronic Lymphocytic Leukemia Research(3), Venous Thromboembolism Diagnosis and Management(2), Viral-associated cancers and disorders(2)

Publications13 total

Prognostic Value of C‐Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma
Hematological Oncology·2025
Author response for "Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma"
2025
Author response for "Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma"
2025
Clinical applicability of the ELN2020 criteria for tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia: insights from a multicenter retrospective study in real-world practice
Leukemia Research·2025· 2 cited
Poor outcome of older patients with diffuse large B-cell lymphoma after progression
Journal of Clinical and Experimental Hematopathology·2025Open Access
Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma
Internal Medicine·2025· 2 citedOpen Access
Factors Predicting Spontaneous Regression in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Diseases
Clinical Lymphoma Myeloma & Leukemia·2025
Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim–Chester Disease Harboring Concurrent <i>BRAF</i><scp><sup>V600E</sup></scp> and <i>KRAS</i><scp><sup>G12R</sup></scp> Mutations: A Case Report
Cancer Reports·2024Open Access
SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment
International Cancer Conference Journal·2024· 2 citedOpen Access
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse
International Journal of Hematology·2024· 3 cited
MO49-1 The efficacy of high-dose versus intrathecal methotrexate for DLBCL with high risk of CNS relapse: A multicenter retrospective study
Annals of Oncology·2023Open Access
The Efficacy of High-Dose Versus Intrathecal Methotrexate for Diffuse Large B-Cell Lymphoma with High Risk of CNS Relapse: A Multicenter Retrospective Study with Uniform CNS Prophylaxis
Blood·2022
Successful treatment with lenalidomide for relapsed adult T-cell leukemia/lymphoma after cord blood cell transplantation
BLOOD CELL THERAPY / The official journal of APBMT·2021· 1 citedOpen Access

Frequent Co-authors

Takuya Miyazaki(9), Rika Sakai(7), Takaaki Takeda(6), Katsumichi Fujimaki(6), Shin Fujisawa(6), Hideaki Nakajima(6), Hiroyuki Takahashi(5), Ayako Matsumura(5), Haruka Teshigawara(5), Hiroshi Teranaka(5), Yuki Nakajima(5), Masatsugu Tanaka(5), Masahiro Akimoto(4), Takuma Ohashi(4), Taisei Suzuki(4), Kenji Matsumoto(4), Chizuko Hashimoto(4), Hiroyuki Fujita(4), Mayumi Tokunaga(4), Yusuke Saigusa(3)